関連する実験動画

Updated: Feb 17, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

PCV2d Cap-COSバイオコンジュガート候補ワクチンの準備と免疫保護効果評価

Shuo Wang¹, Chen Li¹, Jianli Shi¹

¹Key Laboratory of Livestock and Poultry Multi-Omics of Agriculture and Rural Afairs, Shandong Research Center of Livestock and Poultry Biologicals Engineering, Institute of Animal Science and Veterinary Medicine Shandong Academy of Agricultural Sciences, Jinan 250100, China.

|February 16, 2026

まとめ

豚サーコウイルス2型 (PCV2) のカプシドタンパク質 (Cap) を含む新しいキトーサンオリゴサッカライド (COS) コンプレックスは,サブユニットワクチンの有効性を高めています. このPCV2d Cap-COS複合体は免疫反応を高め,挑戦後のブタの成長を改善します.

科学分野:

獣医免疫学獣医免疫学について
バイオコンジューゲーション化学
ワクチンの開発

背景:

豚サーコウイルス2型 (PCV2) は,世界の豚産業界にとって重大な脅威となっている.
PCV2カプシドタンパク質 (Cap) は,サブユニットワクチン開発において重要な抗原である.
効果的なPCV2サブユニットワクチンの開発は,豚の健康にとって優先事項です.

研究の目的:

PCV2d Cap-COS複合体を作るための生物結合戦略を確立する.
マウスモデルでPCV2d Cap-COS複合体の免疫原性と保護効果を評価する.
高効率のPCV2dサブユニットワクチンを開発するための証拠を提供する.

主な方法:

チトサンオリゴサッカリド (COS) とチオール-マレイミドのクリック化学を用いた生物結合戦略が採用されました.
結合的に結合されたPCV2d Cap-COS複合体が構築されました.
免疫とチャレンジの実験はマウスで行われ,JLC-3補助剤を含む配列を用いた.

主要な成果:

JLC-3補助剤を配合したPCV2d Cap-COS複合体は,強固で持続的な特定の免疫反応を誘発した.
複合体で免疫を受けたマウスは,挑戦後の平均毎日の体重増加が有意に改善したことを示した.
肺や腎臓の組織病理学的損傷は,挑戦後に効果的に減少しました.

結論:

PCV2d Cap-COS複合体は,抗原構造と免疫原性を強化する.
このアプローチは,効果的なPCV2dサブユニットワクチンを開発するための新しい戦略を提供します.
この研究は,ワクチン開発におけるCap-COS複合体の使用を支持する実験的証拠を提供します.

さらに関連する動画

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

関連する概念動画

Vaccinations

Vaccinations

Conjugated Proteins

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...